SCRA Announces a $250,000 SC Launch, Inc. Investment in Precision Genetics.

By April 10, 2020 COVID-19

SCRA has provided a $250,000 investment in Precision Genetics through SC Launch to help the company expand its processing of COVID-19 test kits.

“SCRA: South Carolina Research Authority and #SCLaunchInc. stepped up and provided financial commitment and strategic support for us to expedite our efforts. We are desperately trying to serve our community in this time of need, and we are very grateful for the support from SCRA and SC Launch, Inc.” said Nate Wilbourne, CEO of Precision Genetics.

Learn more here.